Literature DB >> 23525502

The Cost of Illness Associated with Stepped Care for Obsessive-Compulsive Disorder.

Gretchen J Diefenbach1, David F Tolin.   

Abstract

Stepped care for obsessive-compulsive disorders (OCD) is a promising approach for improving the accessibility and cost-effectiveness of exposure and response prevention (ERP). Previous research has shown that stepped care is less costly compared with standard, therapist-directed ERP, owing largely to the roughly one-third of patients who respond to lower intensity guided self-help (GSH). The aim of this study was to recalculate the costs of treatment in stepped versus standard care when also including the cost of illness; defined as costs related to functional disability in work, school, and home functioning attributed to OCD symptoms. It was found that the cost savings of stepped care was reduced to a moderate effect (d = 0.66) when the cost of illness was included. Data also indicated substantial potential cost savings if patient-to-treatment matching variables are identified. Exploratory analyses suggested that problems with attention may be an important variable to investigate as a potential treatment moderator in future GSH treatment outcome research. These data highlight the importance of including the cost of illness in cost-effectiveness analyses, and of identifying predictors that will facilitate matched care and prevent unnecessary treatment delay for the roughly two-thirds of patients who will not respond to GSH for OCD.

Entities:  

Keywords:  Cost Effectiveness; Cost of Illness; Obsessive-Compulsive Disorder; Personalized Medicine; Stepped Care

Year:  2012        PMID: 23525502      PMCID: PMC3601841          DOI: 10.1016/j.jocrd.2012.12.005

Source DB:  PubMed          Journal:  J Obsessive Compuls Relat Disord        ISSN: 2211-3649            Impact factor:   1.677


  20 in total

1.  Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms.

Authors:  Luana Marques; Nicole J LeBlanc; Hilary M Weingarden; Kiara R Timpano; Michael Jenike; Sabine Wilhelm
Journal:  Depress Anxiety       Date:  2010-05       Impact factor: 6.505

2.  The effects of antidepressant step therapy protocols on pharmaceutical and medical utilization and expenditures.

Authors:  Tami L Mark; Teresa M Gibson; Kimberly McGuigan; Bong Chul Chu
Journal:  Am J Psychiatry       Date:  2010-08-16       Impact factor: 18.112

3.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Neurocognitive impairment does not predict treatment outcome in obsessive-compulsive disorder.

Authors:  Steffen Moritz; Martin Kloss; Dirk Jacobsen; Susanne Fricke; Carrie Cutler; Stefanie Brassen; Iver Hand
Journal:  Behav Res Ther       Date:  2005-06

5.  Utilization of behavioral methods in a multicenter anxiety disorders study.

Authors:  R M Goisman; M P Rogers; G S Steketee; M G Warshaw; P Cuneo; M B Keller
Journal:  J Clin Psychiatry       Date:  1993-06       Impact factor: 4.384

6.  Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: a preliminary study of efficacy and costs.

Authors:  David F Tolin; Gretchen J Diefenbach; Christina M Gilliam
Journal:  Depress Anxiety       Date:  2011-03-04       Impact factor: 6.505

7.  Rebooting for Whom? Portfolios, Technology, and Personalized Intervention.

Authors:  Varda Shoham; Thomas R Insel
Journal:  Perspect Psychol Sci       Date:  2011-09

8.  Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.

Authors:  Edna B Foa; Michael R Liebowitz; Michael J Kozak; Sharon Davies; Rafael Campeas; Martin E Franklin; Jonathan D Huppert; Kevin Kjernisted; Vivienne Rowan; Andrew B Schmidt; H Blair Simpson; Xin Tu
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

9.  The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder.

Authors:  Christopher A Flessner; Amy Allgair; Abbe Garcia; Jennifer Freeman; Jeffrey Sapyta; Martin E Franklin; Edna Foa; John March
Journal:  Depress Anxiety       Date:  2010-04       Impact factor: 6.505

10.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11
View more
  2 in total

1.  Computer-assisted cognitive behavior therapy for obsessive-compulsive disorder: a randomized trial on the impact of lay vs. professional coaching.

Authors:  Kenneth A Kobak; Revere Greist; David M Jacobi; Hollie Levy-Mack; John H Greist
Journal:  Ann Gen Psychiatry       Date:  2015-02-22       Impact factor: 3.455

2.  Effects of Treatment Setting on Outcomes of Flexibly-Dosed Intensive Cognitive Behavioral Therapy for Pediatric OCD: A Randomized Controlled Pilot Trial.

Authors:  Robert R Selles; Zainab Naqqash; John R Best; Diana Franco-Yamin; Serene T Qiu; Jessica S Ferreira; Xiaolei Deng; Dagmar Kr Hannesdottir; Carla Oberth; Laura Belschner; Juliana Negreiros; Lara J Farrell; S Evelyn Stewart
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.